The Global 2-Amino-6-Methylheptane (DMHA) Market was valued at USD 21.8 Million in 2024 and is projected to reach USD 32.1 Million by 2029, growing at a Compound Annual Growth Rate (CAGR) of 8.0% during the forecast period (2024–2029). The United States market is a significant contributor, driven by robust demand from the pharmaceutical sector and increasing R&D activities for novel therapeutics. This growth is primarily fueled by the expanding use of DMHA as a key pharmaceutical intermediate and its applications in analytical chemistry and specialty chemical synthesis.

As the pharmaceutical and chemical industries continue to innovate, the demand for high-purity intermediates like DMHA is escalating. The market is characterized by the presence of specialized chemical manufacturers and global suppliers who ensure stringent quality control and reliable supply chains. In this blog, we profile the Top 10 Companies in the Global and United States 2-Amino-6-Methylheptane (DMHA) Market—a group of established players and niche specialists shaping the supply landscape for this important chemical compound.

---

🔟 1. MP Biomedicals

Headquarters: Santa Ana, California, USA
Key Offering: High-Purity DMHA (Pharmaceutical and Chemical Grade)

MP Biomedicals is a leading global provider of life science and fine chemicals, offering high-purity 2-Amino-6-Methylheptane for research and industrial applications. The company serves pharmaceutical companies, academic institutions, and research laboratories with a strong emphasis on quality and consistency.

Key Market Initiatives:

• Supply chain optimization for critical pharmaceutical intermediates

• Investment in cGMP-compliant manufacturing processes

• Strategic partnerships with major pharmaceutical developers

Download FREE Sample Report: Global and United States 2-Amino-6-Methylheptane (DMHA) Market – View in Detailed Research Report

---

9️⃣ 2. Tokyo Chemical Industry Co., Ltd. (TCI)

Headquarters: Tokyo, Japan
Key Offering: DMHA (Chemical Grade, Pharmaceutical Grade)

TCI is a premier global manufacturer and supplier of high-purity organic chemicals, including 2-Amino-6-Methylheptane. With a vast product portfolio exceeding 30,000 items, TCI is a trusted partner for research and development across the pharmaceutical and chemical industries worldwide.

Key Market Initiatives:

• Expansion of high-purity fine chemical catalog

• Strengthening distribution networks in North America and Europe

---

8️⃣ 3. Suzhou Uugene Biopharma

Headquarters: Suzhou, Jiangsu, China
Key Offering: Custom Synthesis of DMHA and Derivatives

Suzhou Uugene Biopharma specializes in the custom synthesis and manufacturing of pharmaceutical intermediates, including 2-Amino-6-Methylheptane. The company provides tailored solutions for clients in the pharmaceutical sector, focusing on scalability and regulatory compliance.

Key Market Initiatives:

• Focus on contract research and manufacturing services (CRO/CMO)

• Development of novel synthetic routes for amine compounds

---

7️⃣ 4. Thermo Fisher Scientific (Fisher Scientific)

Headquarters: Waltham, Massachusetts, USA
Key Offering: DMHA for Research and Laboratory Use

Thermo Fisher Scientific, through its Fisher Scientific brand, is a dominant supplier of laboratory chemicals and reagents, including 2-Amino-6-Methylheptane. The company’s extensive distribution network ensures reliable access to high-quality DMHA for academic, government, and industrial research laboratories.

Key Market Initiatives:

• Integration of digital platforms for seamless chemical procurement

• Commitment to sustainable and responsible chemical management

Download FREE Sample Report: Global and United States 2-Amino-6-Methylheptane (DMHA) Market – View in Detailed Research Report

---

6️⃣ 5. Alfa Aesar (Thermo Fisher Scientific)

Headquarters: Haverhill, Massachusetts, USA
Key Offering: High-Purity DMHA, Research Chemicals

Alfa Aesar, part of Thermo Fisher Scientific, is a leading manufacturer and supplier of research chemicals, metals, and materials. The company offers high-purity 2-Amino-6-Methylheptane, catering to the demanding requirements of pharmaceutical R&D and analytical applications.

Key Market Initiatives:

• Maintenance of extensive inventory for rapid delivery

• Focus on purity and batch-to-batch consistency

---

5️⃣ 6. Aurum Pharmatech LLC

Headquarters: San Diego, California, USA
Key Offering: Pharmaceutical Intermediates, Including DMHA

Aurum Pharmatech is a specialized supplier of pharmaceutical intermediates and fine chemicals for the drug discovery and development industry. The company provides 2-Amino-6-Methylheptane to support medicinal chemistry programs and process development.

Key Market Initiatives:

• Specialization in building blocks for medicinal chemistry

• Collaboration with biotech and pharmaceutical innovators

---

4️⃣ 7. Sigma-Aldrich (Merck KGaA)

Headquarters: Darmstadt, Germany (Global Operations in St. Louis, USA)
Key Offering: DMHA under SAFC® and MilliporeSigma brands

As part of Merck KGaA, Sigma-Aldrich is a cornerstone of the global life science industry, supplying 2-Amino-6-Methylheptane for research, development, and production. Its SAFC® brand focuses on high-purity raw materials for pharmaceutical manufacturing.

Key Market Initiatives:

• Investment in quality systems for regulatory compliance (USP, EP)

• Global supply chain resilience for critical materials

---

3️⃣ 8. Waterstone Technology

Headquarters: Carmel, Indiana, USA
Key Offering: Specialty Chemicals and Intermediates

Waterstone Technology is a recognized supplier of specialty chemicals, including fine chemical intermediates like 2-Amino-6-Methylheptane. The company serves a diverse clientele in the pharmaceutical and agrochemical sectors with a focus on quality and customer service.

Key Market Initiatives:

• Strategic sourcing of niche chemical compounds

• Expansion of custom synthesis capabilities

---

2️⃣ 9. Key Organics Ltd.

Headquarters: Camelford, United Kingdom
Key Offering: DMHA for Drug Discovery Screening Libraries

Key Organics is a leading supplier of chemical building blocks and screening compounds for the drug discovery industry. The company includes 2-Amino-6-Methylheptane in its extensive catalog, supporting early-stage research and hit-to-lead optimization.

Key Market Initiatives:

• Curated collections of novel chemical space for screening

• Strong presence in the North American and European markets

Download FREE Sample Report: Global and United States 2-Amino-6-Methylheptane (DMHA) Market – View in Detailed Research Report

---

1️⃣ 10. BOC Sciences

Headquarters: Shirley, New York, USA
Key Offering: DMHA for Pharmaceutical and Research Applications

BOC Sciences is a global chemical supplier and manufacturer providing 2-Amino-6-Methylheptane to the pharmaceutical, biotechnology, and academic research sectors. The company emphasizes reliable supply, competitive pricing, and technical support for its customers.

Key Market Initiatives:

• Comprehensive custom synthesis and manufacturing services

• Robust online platform for chemical sourcing and information

Get Full Report Here: Global and United States 2-Amino-6-Methylheptane (DMHA) Market – View in Detailed Research Report

---

📊 Outlook: The Future of the DMHA Market is Driven by Pharmaceutical Innovation

The 2-Amino-6-Methylheptane market is experiencing steady growth, primarily tethered to the expanding pharmaceutical industry. As drug discovery efforts intensify and the demand for complex molecular structures increases, the need for reliable, high-purity intermediates like DMHA becomes more critical.

📈 Key Trends Shaping the Market:

• Increasing outsourcing of intermediate synthesis by pharmaceutical companies to specialized CROs/CMOs

• Rising demand for chiral amines in the development of active pharmaceutical ingredients (APIs)

• Stringent regulatory requirements driving the need for certified high-purity chemicals

• Geographic expansion of key players to strengthen their global supply chain presence

Get Full Report Here: Global and United States 2-Amino-6-Methylheptane (DMHA) Market – View in Detailed Research Report

The companies profiled above are not only supplying a critical chemical intermediate—they are enabling the advancement of pharmaceutical research and the development of future therapeutics.